Hexokinase 2 (HK2), the initial rate-limiting enzyme in glucose metabolism, catalyzes the conversion of glucose to glucose-6-phosphate (G-6-P) and exhibits significantly increased expression in cervical cancer tissues. Here, HK2 is linked to cervical cancer.